Cargando…
Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
Antibody technology is widely used in the fields of biomedical and clinical therapies. Nonetheless, the complex in vitro expression of recombinant proteins, long production cycles, and harsh storage conditions have limited their applications in medicine, especially in clinical therapies. Recently, t...
Autores principales: | Zhao, Yuxiang, Gan, Linchuan, Ke, Dangjin, Chen, Qi, Fu, Yajuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552228/ https://www.ncbi.nlm.nih.gov/pubmed/37794448 http://dx.doi.org/10.1186/s12967-023-04553-1 |
Ejemplares similares
-
Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
por: Deal, Cailin E., et al.
Publicado: (2021) -
mRNA as novel technology for passive immunotherapy
por: Schlake, Thomas, et al.
Publicado: (2018) -
Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
por: Guevara, Maria L., et al.
Publicado: (2020) -
Passive immunotherapy of viral infections: 'super-antibodies' enter the fray
por: Walker, Laura M., et al.
Publicado: (2018) -
Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination
por: Biswas, Mrityunjoy, et al.
Publicado: (2020)